Does METRELEPTIN Cause Hypertriglyceridaemia? 35 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 35 reports of Hypertriglyceridaemia have been filed in association with METRELEPTIN (Myalept). This represents 3.1% of all adverse event reports for METRELEPTIN.
35
Reports of Hypertriglyceridaemia with METRELEPTIN
3.1%
of all METRELEPTIN reports
0
Deaths
16
Hospitalizations
How Dangerous Is Hypertriglyceridaemia From METRELEPTIN?
Of the 35 reports, 16 (45.7%) required hospitalization.
Is Hypertriglyceridaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METRELEPTIN. However, 35 reports have been filed with the FAERS database.
What Other Side Effects Does METRELEPTIN Cause?
Therapy cessation (94)
Product dose omission issue (88)
Weight decreased (88)
Blood glucose increased (77)
Drug ineffective (69)
Therapy interrupted (65)
Nausea (57)
Off label use (51)
Blood triglycerides increased (49)
Treatment noncompliance (49)
What Other Drugs Cause Hypertriglyceridaemia?
PEGASPARGASE (399)
VINCRISTINE (373)
METHOTREXATE (372)
DEXAMETHASONE (358)
CYTARABINE (244)
CYCLOPHOSPHAMIDE (191)
QUETIAPINE (181)
MERCAPTOPURINE (176)
PREDNISONE (161)
DAUNORUBICIN (143)
Which METRELEPTIN Alternatives Have Lower Hypertriglyceridaemia Risk?
METRELEPTIN vs METRONIDAZOLE
METRELEPTIN vs METRONIDAZOLE\METRONIDAZOLE
METRELEPTIN vs METYRAPONE
METRELEPTIN vs MEXILETINE
METRELEPTIN vs MIANSERIN